Dr. Berry Juliandi and his colleagues at IPB University brought this wild climber, Phanera semibifida, into the clinical light of the laboratory to understand the source of its reputation. The plant is a master of the canopy, anchoring itself to taller trees with delicate tendrils and bearing leaves that fold shut like a pair of wings when the tropical rain begins to fall. In their studies, the researchers found that the traditional intuition of the islanders rests on a precise biological mechanism: the stem extract is dense with polyphenols that inhibit the enzyme alpha-glucosidase, slowing the release of sugar into the bloodstream.
Working alongside Meyla Suhendra, Prof. Huda Darusman, Dr. Siti Sa'diah, and Prof. Fitmawati, Juliandi subjected the plant to rigorous toxicity and efficacy trials. They confirmed that the extract, long known locally as obat pahit, acts as a natural antihyperglycemic therapy, suppressing glucose levels with a safety profile that allows for its development as a standardized medicine.
The significance of this validation comes at a moment of necessity, as Indonesia now ranks among the five nations most affected by diabetes globally. By documenting the science behind the vine, the team has provided the data required to bridge the gap between ancient ethnobotanical practice and modern pharmaceutical standards. It is a quiet victory for the preservation of local knowledge, ensuring that a plant once known only to the forests of the Riau-Lingga Sultanate may now serve the health of the entire republic.